Mioko Matsuo - Publications

Postoperative Unilateral Neck Irradiation for Oral Cancer: Risk Factors for Contralateral Neck Recurrence and Implications for Patient Selection.

Journal: Cureus

Published: May 17, 2026

Prognostic impact of immune-related adverse events in recurrent or metastatic sinonasal squamous cell carcinoma treated with immune checkpoint inhibitors.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: March 03, 2026

Prognostic Difference According to the Site of Origin (Major vs. Minor) of Salivary Gland Carcinoma.

Journal: Anticancer research

Published: February 04, 2026

Long-Term Changes in Olfactory Threshold During Rehabilitation After Total Laryngectomy: A Preliminary Study.

Journal: Laryngoscope investigative otolaryngology

Published: October 20, 2025

Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study).

Journal: International journal of clinical oncology

Published: August 01, 2025

Efficacy of Lenvatinib Therapy for Thyroid Cancer by Pathological Type: A Retrospective Real-world Study.

Journal: In vivo (Athens, Greece)

Published: June 16, 2025

Rare Head and Neck Neuroendocrine Neoplasms: A Retrospective Study of Prognosis and Treatment Outcomes.

Journal: Cancer diagnosis & prognosis

Published: March 15, 2025

Prolonged Postoperative Wound Healing Due to Anti-IL-6 Autoantibody as a Phenocopy of Inborn Errors of Immunity.

Journal: Journal of clinical immunology

Published: March 07, 2025

Surgical treatment of esophago-vertebral fistula and vertebral osteomyelitis after voice prosthesis insertion.

Journal: Auris, nasus, larynx

Published: October 30, 2024

Clinicopathological Review of Head and Neck Squamous Cell Carcinomas After Neoadjuvant Chemotherapy.

Journal: Anticancer research

Published: August 10, 2024

Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study).

Journal: Frontiers in immunology

Published: July 14, 2024

Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation.

Journal: Cancers

Published: June 20, 2024